Akanda Corp. (AKAN) Financials

AKAN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2023 36.5 million 14.9 million
March 31, 2023 39.0 million 12.1 million
Dec. 31, 2022 43.5 million 8.8 million
Sept. 30, 2022 ? ?

AKAN Free Cash Flow and Stock based compensation

No data available :(

AKAN Net Income

No data available :(

AKAN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2023 713338 - 245096
March 31, 2023 492485 - -
Dec. 31, 2022 4.3 million - 330821
Sept. 30, 2022 - - -

AKAN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2023 4.0 million
March 31, 2023 3.5 million
Dec. 31, 2022 3.4 million
Sept. 30, 2022 3.3 million

AKAN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2023 1935 - - -
March 31, 2023 47555 - 3.8 million 3.8 million
Dec. 31, 2022 23777 - - -
Sept. 30, 2022 23777 - 3.8 million 1.4 million

AKAN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2023 1.4 million 4.2 million
March 31, 2023 2.5 million 5.4 million
Dec. 31, 2022 - -
Sept. 30, 2022 1.3 million 314835

AKAN

Price: $15.63

52 week price:
2.30
209.23

Earnings Per Share: 154.84 USD

P/E Ratio: 0.01

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United Kingdom

Market Capitalization: 533715

Links: